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Hemodialysis patients (HD) present inﬂammation, metabolic acidosis and
anorexia which contribute to loss of functional capacity, muscle mass and
strength. Resistance training (RT) is recognized to reduce these effects on the
musculoskeletal system. This study aimed to evaluate the effects of intradialytic
RT on the functional capacity, strength and muscle mass in HD patients.
Eighteen HD patients (50% men, 49.3711.5 years, BMI 22.773.9 kg/m2,
63.2746.3 months on dialysis) exercised 3 times a week for 6 months. All
parameters were evaluated before and after 6 months of RT. There were
signiﬁcant changes in the functional tests 10-TSS (10 times Sit-to-Stand Test)
and SS-60 (amount of sit to stand in 60 seconds), in the muscle mass and % of
body fat after RT. The medial and proximal leg circumferences increased
signiﬁcantly and no differences were observed in torque extensor and ﬂexor
and distal leg circumferences. In conclusion, RT contributes to improving body
composition and functional capacity of HD patients.Parameters Before RT After RT10-TSS (seconds) 27.976.4 21.974.1*SS-60 (repetitions) 26.076.7 28.975.7*Muscle mass - men (kg) 48.079.1 51.5710*Muscle mass - women (kg) 34.174.4 36.974.9*Body fat - men (%) 29.275.1 25.375.1*Body fat - women (%) 34.675.1 32.474.7*LG- Proximal -R (cm) 53.676.6 55.476.7*LG- Proximal -L (cm) 52.775.8 54.176.7
LG- Medial -R (cm) 46.875.1 48.674.9*LG- Medial -L (cm) 46.674.4 48.575.4*LG- Leg circumference; R-right; L- left;
n
po0.01.http://dx.doi.org/10.1016/j.krcp.2012.04.491168
IMPROVING EFFICIENCY OF DIETETIC SERVICES IN CHRONIC KIDNEY
DISEASE WITH A CATEGORISED REFERRAL TOOL
Belinda Morey
Royal Brisbane and Women’s Hospital, Australia
Over the past 3 years the number of CKD patients attending our renal
outpatient service has increased dramatically from under 100 to over 400
patients. In this time dietetic resources within this service have remained
unchanged. This has presented challenges for meeting current practice
guidelines and has created long waiting lists to see the dietitian.
The aim of this project was to determine the current status of dietetic
appointments and reasons for referral. Using this information we proposed
to develop a new referral tool and booking procedures to enable clear
prioritization of patients and appropriate referral pathways.
A nurses’ perceptions questionnaire and a 4-week audit of appointments
were conducted. The new referral tool and booking procedures included
categorisation of clinical dietetic priority, utilisation of other community
dietetic services where appropriate, and explanatory notes of which
patients should take priority in fully booked clinics.
At baseline, it was found that 18 of 57 (31.6%) attempts to book dietetic
appointments were not successful due to fully booked clinics (7 new and
11 reviews). While 6 of the 11 reviews were for reasons of higher dietetic
urgency e.g. hyperkalaemia and malnutrition, 6 out of 7 new referrals were
for lifestyle related reasons e.g. obesity, diabetes, and cholesterol. It is felt
the new categorised referral tool and pathways will provide betterguidance for referral and appropriate use of dietetic resources for CKD
management, to be evaluated in early 2012.
http://dx.doi.org/10.1016/j.krcp.2012.04.492169
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Hyperphosphatemia is recognized as a contributor to vascular
calciﬁcation in patients with chronic kidney disease (CKD) and
hemodialysis (HD) patients and is independently associated with cardiac
mortality. Dietary inorganic phosphorus (Pi) restriction, and the Pi binders
are important therapy for dialysis patients with hyperphosphatemia.
Recent study reported that salivary secretion of Pi to be an important
determinant of hyperphosphatemia in patients with CKD and in those with
ESRD under chronic dialysis. In the present study, we investigated the role
of type IIb sodium-dependent Pi transporter (Npt2b) on salivary Pi
excretion in mice.
The expression of Npt2b protein was detected at the apical side of duct
cells in the salivary glands, suggesting that ductal cells appears to be able
to reabsorb Pi, thereby modifying the Pi concentration in the ﬁnal saliva. In
wild-type mice (Wt mice) fed a high Pi diet, the levels of plasma and
salivary Pi are signiﬁcantly higher than those in mice fed a low Pi diet.
In Npt2bþ /- mice, the salivary Pi concentrations were signiﬁcantly increased
compared with those in Npt2bþ /þ mice. Npt2bþ /- mice with adenine-induced
renal failure had low plasma and salivary Pi levels, and plasma creatinine and
BUN levels compared with Npt2bþ /þ mice treated with adenine. In conclusion,
Npt2b is involved in Pi secretion by salivary glands.
http://dx.doi.org/10.1016/j.krcp.2012.04.493170
A MODIFIED MEAL REPLACEMENT PLAN AS WEIGHT LOSS TREATMENT
IN CHRONIC KIDNEY DISEASE: A CASE STUDY
Belinda Morey, Jillian Murray
Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia
Low calorie liquid meal replacements can be used to achieve weight loss
in obese patients. Many consider renal disease a contraindication to this
due to a lack of speciﬁc research. The aim of this case study is to illustrate
that this therapy can be used effectively in Chronic Kidney Disease (CKD).
After numerous failed weight loss attempts, the multidisciplinary team
(Nephrology, Endocrinology, General Practice and Dietetics) decided to trial a
65 year old patient (CKD Stage 3 secondary to Type 2 Diabetes Mellitus
requiring insulin) on a modiﬁed meal replacement plan. This plan consisted of
3 Optifast meal replacement drinks plus one portion controlled meal, (4MJ
and 85g of protein per day). Monitoring included frequent blood glucose self
testing, fortnightly blood tests and review by the Dietitian (monthly once
stable). The patient was initially unable to exercise due to pain.
At baseline, weight was 157 kg (BMI: 41 kg/m2), waist circumference 155cm
and blood biochemistry indicated CKD stage 3b (eGFR: 39 ml/min, Urea:
15.9 mmol/L, Creat: 156 umol/L). After 14 weeks weight had decreased 22 kg
(BMI: 35.8 kg/m2), waist circumference had decreased 18 cm and reported pain
improved. Insulin requirements approximately halved, and blood biochemistry
(eGFR: 42ml/min, Urea: 15.2 mmol/L, Creat: 147 umol/L) indicated no decline
in renal function. With close monitoring a modiﬁedmeal replacement plan was
used successfully in a patient with CKD however prospective randomised trials
are required to further investigate this treatment.
http://dx.doi.org/10.1016/j.krcp.2012.04.494171
INFLUENCE OF INTENSIVE EXERCISE ON RENAL FUNCTIONS (RF) AND
ADVANCED GLYCATION END-PRODUCTS (AGES)
